Effects of endogenous and exogenous oestrogen exposure on hearing level in postmenopausal women: A cross‐sectional study

2020 ◽  
Author(s):  
Michelle Jee Young Suh ◽  
Sun Kyung Oh ◽  
Soo Bin Lee ◽  
Sung Huhn Kim
Keyword(s):  
Postmenopausal Women ◽  
Cross Sectional Study ◽  
Hearing Level ◽  
Sectional Study ◽  
Cross Sectional ◽  
Exogenous Oestrogen

scholarly journals Depression and Quality of Life among Postmenopausal Women in Bangladesh: A Cross-sectional Study

2017 ◽  
Vol 23 (3) ◽  
pp. 172 ◽  
Author(s):  
Mamun Ibn Bashar ◽  
Kawsar Ahmed ◽  
Muhammad Shahin Uddin ◽  
Farzana Ahmed ◽  
Abdullah-Al Emran ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Postmenopausal Women ◽  
Cross Sectional Study ◽  
Sectional Study ◽  
Cross Sectional

scholarly journals Comparison of Urinary Adiponectin in the Presence of Metabolic Syndrome in Peri- and Postmenopausal Women

2021 ◽  
Author(s):  
Patsama Vichinsartvichai ◽  
Rattana Teeramara ◽  
Titima Jirasawas ◽  
Prirayapak Sakoonwatanyoo
Keyword(s):  
Blood Pressure ◽  
Metabolic Syndrome ◽  
Postmenopausal Women ◽  
Demographic Data ◽  
Diagnostic Value ◽  
Cross Sectional Study ◽  
Sectional Study ◽  
Cross Sectional ◽  
Screening And Diagnosis ◽  
Baseline Demographic

Abstract Objectives To find the association between urinary adiponectin and metabolic syndrome (MetS) in peri- and postmenopausal women and its potential application as a noninvasive screening for MetS. Methods A cross-sectional study was conducted in healthy peri- and postmenopausal women (defined by STRAW+10 staging) age at least 40 years who attended annual checkup or menopause clinic were recruited. Baseline demographic data, MENQOL, anthropometric measurements, blood pressure, laboratory (FBS, total cholesterol, HDL-C, LDL-C, TG) and urinary adiponectin were collected. The MetS was diagnosed according to JIS 2009. Results 290 peri- and postmenopausal women had participated. The prevalence of Mets among our participants was 18%. Urinary adiponectin levels were similar in peri- and postmenopausal women with and without MetS (2.6±2.2 vs 2.3±1.9 ng/mL, respectively, P = 0.55). Urinary adiponectin provides no diagnostic value for MetS (AUC = 0.516). Conclusions Urinary adiponectin has no role in screening and diagnosis of MetS in peri- and postmenopausal women. The quest toward noninvasive screening for MetS is still going on.

scholarly journals Knowledge, attitude and experiences of menopause in the postmenopausal women at a tertiary care center: a cross sectional study

2018 ◽  
Vol 7 (11) ◽  
pp. 4758
Author(s):  
Shivraj More ◽  
Sujatha P. ◽  
Karthiga Karthiga
Keyword(s):  
Postmenopausal Women ◽  
Care Center ◽  
Tertiary Care ◽  
Educational Status ◽  
Cross Sectional Study ◽  
Reproductive Age ◽  
Tertiary Care Center ◽  
Sectional Study ◽  
Cross Sectional ◽  
The Government

Background: Menopause is an inevitable milestone in the reproductive life of every woman. The objective is to investigate menopausal knowledge, attitude, symptoms and management among the participants, to identify the differences according to their educational status and to examine correlations of knowledge, attitude and symptoms pertaining to menopause.Methods: This cross-sectional study was conducted for a period of 10 months in postmenopausal women attending a tertiary care center in Pondicherry, India with a structured questionnaire developed on the basis of the objective of the study.Results: 330 postmenopausal women were recruited, and all were aware of their postmenopausal status. Mean age at menopause was 45.91±2.66 years. 54.5% were aware about what menopause was while 5.5% were unaware. 12.1% had proper knowledge about cause of menopause, whereas 3.6% said it is due to god’s decision / turning point. Most prevalent symptoms were tiredness (89.6%) followed by vasomotor symptoms like hot flushes (88.5%) and night sweats (80.3%). Only 2.1% had used HRT for menopausal symptoms.Conclusions: Depth of knowledge is more important when concern is about greater health disrupter which tends to be imperceptible for a long time such as bone health and cardiovascular risk profile. Thus, the government could concentrate on providing health services to women in post reproductive age group also besides women in the reproductive age.

scholarly journals Breast density in women with premature ovarian failure or postmenopausal women using hormone therapy: analytical cross-sectional study

2010 ◽  
Vol 128 (4) ◽  
pp. 211-214 ◽  
Author(s):  
Patrícia Magda Soares ◽  
César Cabello ◽  
Luis Alberto Magna ◽  
Eduardo Tinois ◽  
Cristina Laguna Benetti-Pinto
Keyword(s):  
Hormone Therapy ◽  
Postmenopausal Women ◽  
Breast Density ◽  
Premature Ovarian Failure ◽  
Cross Sectional Study ◽  
Ovarian Failure ◽  
Sectional Study ◽  
Cross Sectional ◽  
Significant Difference ◽  
The Impact

CONTEXT AND OBJECTIVE: Studies on postmenopausal women have reported increased risk of breast cancer relating to the type and duration of hormone therapy (HT) used. Women with premature ovarian failure (POF) represent a challenge, since they require prolonged HT. Little is known about the impact of prolonged HT use on these women's breasts. This study aimed to evaluate the effects of one type of HT on the breast density of women with POF, compared with postmenopausal women. DESIGN AND SETTING: Cross-sectional study at the Department of Obstetrics and Gynecology, Universidade Estadual de Campinas (Unicamp). METHODS: 31 women with POF and 31 postmenopausal women, all using HT consisting of conjugated equine estrogen combined with medroxyprogesterone acetate, and matched according to HT duration, were studied. Mammography was performed on all subjects and was analyzed by means of digitization or Wolfe's classification, stratified into two categories: non-dense (N1 and P1 patterns) and dense (P2 and Dy). RESULTS: No significant difference in breast density was found between the two groups through digitization or Wolfe's classification. From digitization, the mean breast density was 24.1% ± 14.6 and 18.1% ± 17.2 in the POF and postmenopausal groups, respectively (P = 0.15). Wolfe's classification identified dense breasts in 51.6% and 29.0%, respectively (P = 0.171). CONCLUSION: There was no difference in breast density between the women with POF and postmenopausal women, who had used HT for the same length of time. These results may help towards compliance with HT use among women with POF.

Diastasis recti abdominis and pelvic floor dysfunction in peri- and postmenopausal women: a cross-sectional study

2020 ◽  
pp. 1-7
Author(s):  
Beatriz Souza Harada ◽  
Thainá Tolosa De Bortolli ◽  
Letícia Carnaz ◽  
Marta Helena Souza De Conti ◽  
Adoniz Hijaz ◽  
...  
Keyword(s):  
Pelvic Floor ◽  
Postmenopausal Women ◽  
Pelvic Floor Dysfunction ◽  
Cross Sectional Study ◽  
Sectional Study ◽  
Cross Sectional ◽  
Diastasis Recti ◽  
Diastasis Recti Abdominis
Sign in / Sign up

Export Citation Format

Share Document